The CDC reports an uptick in cancer-related events since the start of COVID-19 mRNA vaccinations.
Specifically, VAERS data shows 2,579 cancer events from December 2020 to August 2022. In contrast, other vaccines led to 791 cancer events from 2008 to 2020.
Moreover, flu shots had only 64 such events, despite 1.7 billion doses administered over 13 years.
When measured per 100,000 doses, flu shots had 0.0003 cancer-related events. Meanwhile, COVID-19 shots show 0.43 events per 100,000 doses.
This information triggers questions about the mRNA vaccine’s safety. A 2021 study found that the SARS-CoV-2 spike protein could affect cell DNA repair paths.
However, more research is needed to confirm these findings. Experts advise that correlation does not confirm causation.
Multiple interpretations of this data exist, making the scientific community divided. Independent, peer-reviewed studies will offer more clarity.
For now, people should consult trusted health experts when considering the vaccine. As data keeps coming in, public health updates will be crucial.
This ongoing analysis will help us understand vaccine safety better.
Background
The recent data on cancer cases post-COVID-19 vaccination require scrutiny. It’s important to note that VAERS is a self-reporting system, which could include reporting biases.
mRNA vaccines underwent trials prior to their emergency use authorization, but some argue that these trials did not meet typical standards.
Still, the rise in reported cancer cases is an area for further investigation.
The vaccines have primarily been deployed to combat a global health crisis that has caused many deaths.
These vaccines have demonstrated effectiveness in reducing severe COVID-19 cases.
However, the increase in reported cancer cases post-vaccination warrants further research. Peer-reviewed studies will be essential for more conclusive insights.
People should make vaccination decisions based on comprehensive, up-to-date information. Consult with healthcare professionals for personalized advice.
Read More from The Rio Times